SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-098807
Filing Date
2024-08-19
Accepted
2024-08-19 20:23:20
Documents
2
Period of Report
2024-08-14

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 10288
2 EX-24 tnya-ex24.htm EX-24 6391
  Complete submission text file 0000950170-24-098807.txt   18188
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address
Saito Chihiro (Reporting) CIK: 0002034025 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40656 | Film No.: 241222355